The cefotaxime is a broad spectrum cephalosporin antibiotic. It is mainly used in the treatment of bacterial infections. Cefotaxime is a suitable candidate for controlled release administration due to its short elimination time 1 hour. The main aim of the present investigation is to increase the gastric residence time by preparing floating drug delivery by using raft forming approach thereby improving bioavailability. The prepared Cefotaxime floating drug delivery by using raft forming approach were evaluated for hardness, weight variation, thickness, friability, drug content uniformity, total floating time, In-vitro dissolution studies and buoyancy lag time. Floating tablets were formulated using direct compression technique. Various polymers are used in the formulation they Micro crystalline cellulose used as binder, HPMC K15M, Guargum used as hydrophilic polymers, Chitosan, Sodium bicarbonate was incorporated as an effervescent substance, Sodium alginate used as viscous gel forming agent, Magnesium streate used as lubrication, talc was used as diluent. The formulated Cefotaxime tablet to be evaluated the following parameters as follow Weight variation (mg), Hardness, Thickness, Friability, Drug content uniformity, Floating lag time, the in vitro cumulative amount of drug released was shown the F7 is 99.28% within 45 minutes the comparative studies with marketed formulations F7 show the better results.
INTRODUCTION
The Oral administration is the most convenient and preferred means of any drug delivery to the systematic circulation 1 . Oral controlled release drug delivery have recently been of increasing interest in pharmaceutical field to achieve improved therapeutic advantages, such as ease of dosing administration, patient compliance and flexibility in formulation. This route has high patient acceptability, primarily due to ease of administration. Over the years, oral dosage forms have become increasingly sophisticated with major role being played by control release drug delivery system 2 . The Control release drug delivery system release drug at a predetermined rate, as determined by drug's pharmacokinetics and desired therapeutic concentration. Raft forming system has received much attention for the delivery of antacids and drug delivery for gastrointestinal infections and disorders. The basic mechanism involved in the raft formation includes the formation of viscous cohesive gel in contact with gastric fluids, wherein each portion of the liquid swells forming
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[111] CODEN (USA): JDDTAO a continuous layer called raft. The raft floats because of the buoyancy created by the formation of co 2 and act as barrier to prevent the reflux of gastric content like HCl and enzymes into the esophagus. Usually, the system contains a gel forming agent and alkaline bicarbonates or carbonates responsible for the formation of to make the system less dense and float on the gastric fluids 3 . The floating drug delivery system by raft forming method enhances the absorption of drug in stomach and also to increase the bioavailability of drug. Gastric retentive time is increased because of buoyancy studies to avoidance of gastric irritation 4 . These delivery system also used to reduce the development of drug resistant bacteria and maintain the effectiveness of cefotaxime and other antibacterial drugs. It should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Cefotaxime sodium is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis 5 . Cefotaxime has activity in the presence of some beta lactamases, both penicillinases and cephalosporinases, of Gram negative and Gram positive bacteria. Cefotaxime is a β-lactam antibiotic as a class, β-lactams inhibit bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins.
MATERIALS AND METHODS:
Cefotaxime was procured as a gift sample from Hetero Drug Limited, Hyderabad, India. Microcrystalline cellulose, Sodium alginate & HPMCK15M was obtained from Pharmaceutical Pvt Ltd, Mumbai. Guar gum & chistosan was obtained from India sea foods cochin, Sodium bicarbonate, talc & Magnesium stearate was obtained form S.D. Fine Chemical Ltd, Mumbai. All other reagents used were of analytical grade.
Methodology

Compatability Studies
FTIR Studies: The compatibility between pure drug and polymer like Cefotaxime, HPMC K15M, guar gum, chitosan and mixture of compounds were prepared in the form of KBr Pellets and subjected for scanning from 4000 cm‾ 1 to 400 cm‾ 1 using FTIR spectroscopy 6 .
Formulation of Floating Tablet of Cefotaxime
The Floating Raft forming approach tablets of cefotaxime were prepared through direct compression method. The preparations of Cefotaxime by various steps involved in tablet production are sieving, mixing, lubrication and compression 7 . Microcrystalline cellulose use as binder, HPMC K 15M used as synthetic hydrophilic polymer. Guar gum and chitosan used as natural hydrophilic polymer. Sodium alginate use as viscous gel forming, sodium bicarbonate used as gas generating agent. Talc is used as diluents, magnesium stearate used as lubricant. Finally, the powder mixture was compressed into tablets using rotator tablet punching machine at the weight of 500mg each. The below expressed gastro retentive drug delivery of cefotaxime tablets performed a different formulation from F1 to F9 batches study with various concentrations of different polymers. 
110Total (mg) 500 500 500 500 500 500 500 500 500
All formulation are shown in mg
Pre Compression Parameters
Angle of repose: Angle of repose is defined as the maximum angle between the surface of pile of the powder and the horizontal plane 10 . Fixed funnel method was used. A funnel was fixed with its tip at a given height (h), above a flat horizontal surface on which a graph paper was placed. Powder was carefully poured through the funnel until the apex of the conical pile formed just reached the tip of the funnel 8 . These studies were carried out before and after incorporating lubricant/glidant. The angle of repose (ѳ) was then calculated.
Ѳ = tan‾ 1 (h/r)
Where ѳ = Angle of repose, h =Height of pile, r = Radius of the base of pile.
Bulk density: Bulk density was determined by using bulk density apparatus, during measurement accurately weighed quantity of the powder were taken in a measuring cylinder and recording the volume and weight of the total powder 9 . Bulk density is expressed in gm/ml and is given by, 11 . A material having values less than 20 to 30% is defined as the free flowing material, based on the apparent bulk density and tapped density, the percentage compressibility of the bulk drug was determined by using the following formula.
Compressibility index = × 100
Where, TD = Tapped density of the powder, BD = Bulk density of the powder.
Hausner's ratio: It indicates the flow properties of the powder. The ratio of tapped density to bulk density of the powder is called Hausner's ratio.
Hausner's Ratio=TD/BD Where, TD = Tapped density of the powder, BD = Bulk density of the powder.
Post Compression Parameters
Hardness: The hardness of ten tablets was measured using Monsanto tester. Resistance of the tablet during transportation or breakage under storage conditions and handling before usage depends on its hardness 12 . The hardness was measured in terms of kg/cm 2 . Five tablets were chosen randomly and tested for hardness. The average hardness of five tablets was recorded.
Thickness: Thickness was measured using a calibrated vernier calliper. It was determined for check the thickness of tablet 13 . Five tablets of each formulation were picked randomly and thickness was measured individually.
Friability:
The friability of the prepared tablets was determined using Roche friability apparatus. It is expressed in percentage (%). To calculate the percentage friability determines 10 tablets initial weight and transferred into friabilator. The friabilator was operated at 25 rpm for four minutes 14 . After four minutes the tablets were weighed again. Then % friability was then calculated using formula.
% Friability = ×100
Weight variation: The weight of the tablet being made was determined to ensure that a tablet contains the proper amount of drug. Twenty tablets were selected at random from each formulation and weighed on electronic weighing balance. The average weight of the tablets was determined 15 . The weight of individual tablets was compared with the average weight variation.
Drug content uniformity:
The drug content of prepared tablets was accurately weight and finely powered by pestle in a mortar. Weighed tablet of each powder equivalent to 400mg of cefotaxime was transferred in to volumetric flask, dissolved in 60ml of 0.1N HCL and content of the flask were sonicated for 15 minutes. Then the volume was made up to100ml 16 . The samples were analyzed UV-Visible spectrophotometer, and concentration of the drug in the sample was calculated.
In-Vitro Buoyancy Studies: The in vitro buoyancy was determined by floating lag time. The time between introduce of dosage form and its buoyancy on the simulated gastric fluid and the time during which the dosage form remain buoyant were measured. The time taken for dosage form to emerge on surface of medium called floating lag time. Method described by the tablets was placed in a 100ml beaker containing 0.1 N HCL. The time required for the tablet to rise to the surface and float was determined as floating lag time 17 .
In-vitro dissolution studies: Dissolution of the tablets was carried out on USP XXXIII dissolution type II apparatus using paddle. The tablet was fixed to the paddle by hydration mechanism 900 ml of 0.1N HCL as dissolution medium was filled in a dissolution vessel and the temperature of the medium was set at 37± 0.5 o c. The rotational speed of the paddle was set at 100 rpm 18 . At particular intervals 5 ml of sample was withdrawn at predetermined time intervals of 5 mints, 10 mints, 15 mints, 20 mints, 25 mints, 30 mints, 35 mints, 40 mints, 45 mints and same volume of fresh medium was replaced. The withdrawn samples were diluted to 10 ml with 0.1N HCL, filtered and analyzed on UV spectrophotometer at 752 nm 0.1NHCL using buffer as a blank. Percentage cumulative drug release was calculated.
Raft strength measurement by in house method: A tablet powder equivalent to unit dose was transferred to 150 ml of 0.1N HCL and maintained at 37ºc in a 250 ml glass beaker. Each raft was allowed to form around an L-shaped wire probe (diameter: 1.2mm) held upright in the beaker throughout the whole period (30 min) of raft development. Raft strength was estimated using the modified balance method 19 . Water was added drop wise to the pan and the weight of water required to break the raft was recorded.
Data analysis:
To analyze the mechanism of release and release rate Zero order, first order, Higuchi matrix and Peppa's model. Based on the r-value, the best-fit model was selected Zero order kinetics: Drug dissolution from pharmaceutical dosage forms that do not disaggregate and release the drug slowly, assuming that the area does not change and no equilibrium conditions are obtained can be represented by the following equation 
First order kinetics:
To study the first order release rate kinetics, the release rate data were fitted to the following equation 21 . 
Log
If the Higuchi model of drug release is obeyed, then a plot of Mt/M∞ versus t1/2 will be straight line with slope of KH.
Korsmeyer-Peppas Model:
The power law describes the fractional drug release is exponentially related to the release time and adequately describes the release of drug from slabs, cylinders and spheres, as expressed in following equatiion 23 .
Mt / M∞ = Ktn
Log (Mt / M∞) = log K + n log t Stability Studies: Accelerated stability study of gastro retentive drug delivery of cefotaxime (100mg) brand name was claforan by using raft forming approach. Stability study of tablets containing Cefotaxime was performed at following temperatures for one month and three months 24 .
Long term testing: 25oC/ 60%RH (1Month) (3Month)
Accelerated testing: 40oC/75% RH (1Month) (3Month)
RESULTS AND DISCUSSION
Preformulation studies: Hausner's ratio: The Hausner's ratio of powder mix was determined by the data of loose bulk density and tapped bulk density. The Hausner's ratio for all the formulations lies within the range of 1.05 to 1.20, which indicates flow of powder is excellent. None of the formulations were exceeding the limit ±5% specified by IP. Thus all the formulations were found to comply with the IP standard.
Hardness of the tablets:
The tablet hardness of all the formulations was checked using Monsanto hardness tester, by the method described in methodology section.
The average hardness of all the batches is in the range of 4.5 to 3.5 kg/m 2 . The lower standard deviation values indicated that the hardness of all the formulations were almost uniform in specific method and possess good mechanical strength with sufficient hardness. Results as shown in table 4. The hardness of all formulations was found to be in acceptable range.
Friability of the tablets:
The friability test is designed to evaluate the ability of the tablet to withstand abrasion in packaging, handling and shipping. A number of tables were weighed and placed in tumbling apparatus where they were exposed to rolling and 50 resolutions resulting from freefalls within the roche's apparatus. Results as shown in table 4. The percentage friability for all the formulations lies in the range of 0.12% to 0.45%, which was found to be in limit (i.e. <1%).
Estimation of drug content:
All the formulations were evaluated for the drug content estimation in 0.1NHCl sample of tablets using the procedure described in methodology section. Results as shown in table 4. The drug content values for all the formulations are in the range of 98 to 99%. Each value represents the mean ± standard deviation
In-vitro drug release studies:
The In-vitro dissolution study of Cefotaxime tablet floating drug delivery by using raft forming approach, 0.1N HCl as dissolution medium. The In-vitro drug release study of Cefotaxime tablets from each batch (F1 to F9) was carried out by using 0.1N HCl for 45 Mints. The samples were withdrawn at specified time intervals and analyzed by UV-visible spectrophotometer. Percentage drug release was calculated on the basis of mean amount gastro retentive of Cefotaxime present in respective formulation. The cumulative percentage of drug release of floating drug delivery of Cefotaxime on y-axis was plotted against time on x-axis to obtain drug release profiles.
Drug Release Kinetics:
The release constant was calculated from the slope of the appropriate plots, and the regression coefficient (r 2 ) was determined The drug release data obtained were extrapolated by Zero order, First order, Higuchi model and Korsmeyer-Peppas plot for Best Formulation F7. The release kinetics shows that the release of drug followed zero order release in all the formulations. 
SUMMARY
The cefotaxime drug is used for the treatment for antibacterial disease by the mechanism bactericidal action of cefotaxime inhibits cell wall synthesis. It binds the penicillin binding proteins. The main of this project work to improve the patient complains quick relies of the drug, improve bioavailability and improve therapeutic effectiveness. For this purpose formulate the floating drug delivery of cefotaxime tablet by using raft forming approach. Drug polymer compatibility studies by observing physical observation, FTIR, analysis revealed that there was no significant physical & chemical interaction between the drug and polymers. Hence, the selected raw materials were more suitable for the formulation of cefotaxime tablet linearity of the curve was observed in the calibration curve, which was found to be wavelength 752 nm. Nine formulations were prepared by using the different ratios of the polymers such as the HPMC K15M, Guargum, Chitosan, Sodium bicarbonate was in cooperated as an effervescent substance to study the buoyancy of the dosage form due to liberation of co 2 , Sodiumalginate is used as viscous gel forming agent, Microcrystalcellulose used as binder, Talc is used as diluents, Magnesium stearate lubricant. The formulated cefotaxime tablet to be evaluated the following parameters as follow Weight variation, Hardness, Thickness, Friability, Drug content uniformity, Floating lag time, the in vitro cumulative amount of drug released was shown the F7 is 98% within 12 Hours the comparative studies with marketed formulations F7 show the better results.
CONCLUSION:
From the experimental results, it can be concluded that the sodium bicarbonate and sodium alginate has shown a predominant effect on the buoyancy lag time, while HPMC K15M and Guar gum have the predominant effect on drug release. Floating drug delivery of cefotaxime tablet has controlled release. In vitro release rate studies showed that the maximum drug release was observed F7 formulation upto 12 hours. From the study it is evident that promising controlled release tablets of cefotaxime can be developed. Further detailed investigations are required to establish efficacy of these formulations. 
